why choose us

First received: July 25, 2023

Clinical Trial: A Study to Access the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)

Study Status: Completed

Recruit Status: RECRUITING

Condition: ADHD

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Solriamfetol in Adults

Brief Summary: FOCUS (Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group trial to assess the efficacy and safety of solriamfetol in adults with ADHD.

Read more